Showing results (791-800 of 2,736) with videos related to

Sort By:
Pageof 274
Expert Review of Neurotherapeutics|September 14, 2021
Cutting edge approaches to detecting brain mosaicism associated with common focal epilepsies: implications for diagnosis and potential therapiesZimeng Ye, Mark F Bennett, Melanie Bahlo, et al.
Expert Review of Neurotherapeutics|September 16, 2021
Redefining the strategy for the use of COMT inhibitors in Parkinson's disease: the role of opicaponePeter Jenner, José-Francisco Rocha, Joaquim J Ferreira, et al.
Expert Review of Neurotherapeutics|April 11, 2020
The correlation between feeding intolerance and poor prognosis of patients with severe neurological conditions: a case-control studyJingjing Peng, Guangwei Liu, Feng Li, et al.
Expert Review of Neurotherapeutics|April 21, 2020
MRI biomarkers of disease progression and conversion to secondary-progressive multiple sclerosisEleonora Tavazzi, Robert Zivadinov, Michael G Dwyer, et al.
Expert Review of Neurotherapeutics|April 21, 2020
Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment optionsMattia Rosso, Shrishti Saxena, Tanuja Chitnis
Expert Review of Neurotherapeutics|May 17, 2021
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsyMichele Ascoli, Giovanni Mastroianni, Sara Gasparini, et al.
Expert Review of Neurotherapeutics|August 14, 2021
A critical review of the neurovascular nature of migraine and the main mechanisms of action of prophylactic antimigraine medicationsBruno A Marichal-Cancino, Abimael González-Hernández, Raquel Guerrero-Alba, et al.
Expert Review of Neurotherapeutics|June 16, 2020
Metabolomics markers in Neurology: current knowledge and future perspectives for therapeutic targetingRoberta Bonomo, Guido Cavaletti, Debra J Skene
Expert Review of Neurotherapeutics|November 30, 2021
What is the role of placebo in neurotherapeutics?Elisa Frisaldi, Aziz Shaibani, Marco Trucco, et al.
Expert Review of Neurotherapeutics|November 5, 2021
Adaptive, personalized closed-loop therapy for Parkinson's disease: biochemical, neurophysiological, and wearable sensing systemsLazzaro di Biase, Gerd Tinkhauser, Eduardo Martin Moraud, et al.
Pageof 274